Ulcer and gastritis

Five papers, discussing important topics related to ulcer and gastritis, have been selected for review here. The papers, which include some excellent systematic reviews and meta-analyses, were published between July 2005 and August 2006.

References

• 1 Dixon M F, Genta R M, Yardley J H. et al . Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.  Am J Surg Pathol. 1996;  20 1161-1181
• 2 Naito Y, Ito M, Watanabe T. et al . Biomarkers in patients with gastric inflammation: a systematic review.  Digestion. 2005;  72 164-180
• 3 Ernst P B, Peura D A, Crowe S E. The translation of Helicobacter pylori basic research to patient care.  Gastroenterology. 2006;  130 188-206
• 4 Ouburg S, Bart A, Crusius J. et al . A candidate gene approach of immune mediators effecting the susceptibility to and severity of upper gastrointestinal tract diseases in relation to Helicobacter pylori and Epstein-Barr virus infections.  Eur J Gastroenterol Hepatol. 2005;  17 1213-1224
• 5 Tsai C J, Herrera-Goepfert R, Tibshirani R J. et al . Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy.  Cancer Epidemiol Biomarkers Prev. 2006;  15 272-280
• 6 Lu B, Chen M T, Fan Y H. et al . Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study.  World J Gastroenterol. 2005;  11 6518-6520
• 7 Mera R, Fontham E T, Bravo L E. et al . Long term follow up of patients treated for Helicobacter pylori infection.  Gut. 2005;  54 1536-1540
• 8 You W C, Brown L M, Zhang L. et al . Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.  J Natl Cancer Inst. 2006;  98 974-983
• 9 You W C, Zhang L, Grail M H. et al . Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors.  J Natl Cancer Inst. 2000;  92 1607-1612
• 10 Hippisley-Cox J, Coupland C, Logan R. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.  BMJ. 2005;  331 1310-1316
• 11 Scheiman J M, Yeomans N D, Talley N J. et al . Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.  Am J Gastroenterol. 2006;  101 701-710
• 12 Huang J-Q, Sridhar S, Hunt R H. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.  Lancet. 2002;  359 13-22
• 13 Papatheodoridis G V, Sougioultzis S, Archimandritis A J. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review.  Clin Gastroenterol Hepatol. 2006;  4 130-142
• 14 Lin H J, Lo W C, Cheng Y C. et al . Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.  Am J Gastroenterol. 2006;  101 500-505
• 15 Andrews C N, Levy A, Fishman M. et al . Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.  Can J Gastroenterol. 2005;  19 667-671
• 16 Cook D J, Guyatt G H, Salena B J. et al . Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis.  Gastroenterolgy. 1992;  102 139-148
• 17 Consensus conference: therapeutic endoscopy and rebleeding ulcers (review).  JAMA. 1989;  262 1369-1372
• 18 Kahi C J, Jensen D M, Sung J J. et al . Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis.  Gastroenterology. 2005;  129 855-862
• 19 Lau W Y, Leong K I, Kwong K H. et al . A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique.  Ann Surg. 1996;  224 131-138
• 20 Siu W T, Leong K I, Law B K. et al . Laparoscopic repair for perforated peptic ulcer: a randomized controlled trial.  Ann Surg. 2002;  235 313-319
• 21 Lunevicius R, Morkevicius M. Systematic review comparing laparoscopic and open repair for perforated peptic ulcer.  Br J Surg. 2005;  92 1195-1207
• 22 Lunevicius R, Morkevicius M. Management strategies, early results, benefits, and risk factors of laparoscopic repair of perforated peptic ulcer.  World J Surg. 2005;  29 1299-1310
• 23 Boey J, Choi S K, Poon A. et al . Risk stratification in perforated duodenal ulcer: a prospective validation of predictive factors.  Ann Surg. 1987;  205 22-26